학술논문
First-line ceritinib versus platinum-based chemotherapy in advanced ALK-rearranged non-small-cell lung cancer (ASCEND-4): a randomised, open-label, phase 3 study
Document Type
Article
Author
Soria, Jean-Charles; Tan, Daniel S W; Chiari, Rita; Wu, Yi-Long; Paz-Ares, Luis; Wolf, Juergen; Geater, Sarayut L; Orlov, Sergey; Cortinovis, Diego; Yu, Chong-Jen; Hochmair, Maximillian; Cortot, Alexis B; Tsai, Chun-Ming; Moro-Sibilot, Denis; Campelo, Rosario G; McCulloch, Tracey; Sen, Paramita; Dugan, Margaret; Pantano, Serafino; Branle, Fabrice; Massacesi, Cristian; de Castro, Gilberto, Jr
Source
In The Lancet 4-10 March 2017 389(10072):917-929
Subject
Language
ISSN
0140-6736